MedCity News
APRIL 18, 2025
How can physicians and patients be confident enough that vendors entirely ignorant of the FDA process for repair and reporting can properly recalibrate life-saving machines? Is this really the right place to argue that anyone can do it? The post Medical Device Right to Repair is the Wrong Approach appeared first on MedCity News.
Evolve Your Success
APRIL 23, 2025
Breaking Barriers: Navigating the Evolving World of Healthcare and Medical Sales. Join Jasper Freeman, Director of National Accounts at SC Pharmaceuticals, as he shares his transformative journey in medical sales. From pioneering the heart failure treatment device, Ferosix, to making groundbreaking strides in home healthcare, Jasper unveils how cutting-edge technology is reducing hospital visits and revolutionizing patient care.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Integrity Solutions
APRIL 17, 2025
In stable markets, as our businesses are growing, investing in sales training is a relatively standard part of the acceleration process. Once you find the right type of training to support your team and culture, your company hits the “go” button and it’s full speed ahead. Fueled both by the skills and confidence of the team and a predictable, healthy external environment, the payoff comes relatively quickly in the form of higher productivity, quota attainment and overall revenu
European Pharmaceutical Review
APRIL 21, 2025
For the first time in over ten years, the US Food and Drug Administration (FDA) has approved a new targeted treatment for chronic spontaneous urticaria. Sanofi and Regeneron Pharmaceuticals collaborated to develop Dupixent (dupilumab). Under the FDA’s new authorisation, the therapy is indicated for individuals aged 12 years and over with the chronic inflammatory skin disease, who still experience symptoms despite taking histamine-1 (H1) antihistamine medication.
Advertiser: ZoomInfo
AI adoption is reshaping sales and marketing. But is it delivering real results? We surveyed 1,000+ GTM professionals to find out. The data is clear: AI users report 47% higher productivity and an average of 12 hours saved per week. But leaders say mainstream AI tools still fall short on accuracy and business impact. Download the full report today to see how AI is being used — and where go-to-market professionals think there are gaps and opportunities.
PharmaVoice
APRIL 16, 2025
Lower operating costs and a supply of high-skilled workers are helping the North Carolina region pull in billions of pharma manufacturing investments.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
Pharma Marketing Network
APRIL 16, 2025
Imagine launching a brand campaign without guessworkwhere your message reaches the right healthcare professional at the right time on the right channel. Thats the promise of data-driven marketing , a strategy thats rapidly transforming how pharmaceutical companies approach promotion, education, and engagement in 2025. As privacy regulations evolve, customer expectations change, and AI-driven technologies emerge, pharma marketers must adapt or risk becoming irrelevant.
PM360
APRIL 21, 2025
Q. As your company is part of the ecosystem which represented the fourth largest career path vertical for MIT Sloans Class of 2023 , clearly there is interest in students entering this arena. How can the MIT education be applied to firms at the intersection of engineering, healthcare and management? ( Tina Tianning Yu): With the global medical devices market size projected to increase from last years approximate $518 Billion to $886 Billion in 2032 , the sector is a fertile ground for graduates
European Pharmaceutical Review
APRIL 17, 2025
Over the past decade, we have witnessed the arrival of a new era in biopharmaceutical R&D. Traditional methods and processes, such as wet labs, are being augmented by a rapidly expanding digital ecosystem in pharma. Across the industry, this shift is offering extraordinary opportunities to increase the speed, accuracy, and reproducibility of research.
PharmaVoice
APRIL 18, 2025
Compass Pathways expects to publish the first phase 3 results from a large-scale, psilocybin drug trial by the end of this quarter.
Speaker: Jesse Hunter and Brynn Chadwick
Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.
MedCity News
APRIL 17, 2025
The first Phase 3 results for Eli Lillys daily pill orforglipron show statistically significant reductions in blood sugar and body weight in patients with type 2 diabetes. The pharmaceutical giant plans global regulatory submissions starting at the end of this year. The post Eli Lillys Metabolic Medicine Takes the Lead in the Race to Develop an Oral GLP-1 Drug appeared first on MedCity News.
Pharma Marketing Network
APRIL 23, 2025
Introduction In 2025, the pharmaceutical industry finds itself in the midst of a digital transformation, where trust and personalization are more important than ever. Pharma brands are no longer competing solely on productstheyre competing on relationships. As a result, customer engagement strategies have taken center stage in shaping how companies connect with healthcare professionals (HCPs), patients, caregivers, and stakeholders.
Curzon Consulting
APRIL 17, 2025
The issue Shrinking customer base 13 legacy books and numerous policy variants causing customer and staff confusion Operationally complex to manage high cost to serve Existing proposition and pricing created trigger points for customer exit Customers not segmented by value No differentiated renewal or save strategies Not pricing for risk or maximised value retention Poor customer journey: passed from function to function, advisors not empowered Solution Designed and executed a pricing, product
European Pharmaceutical Review
APRIL 17, 2025
Researchers in Spain have developed a new method to deliver cell therapies to patients on extracorporeal membrane oxygenation (ECMO), a life support system for severe lung failure. The consecutive intrabronchial administration (CIBA) method enables a new route of delivery: targeted, controlled, fractionated intrabronchial delivery. The researchers referred to the novel approach as slow consecutive intrabronchial lobe-by-lobe administration.
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
PharmaVoice
APRIL 22, 2025
The discoveries also hold potential benefits for patients with other conditions, such as chronic fatigue syndrome.
MedCity News
APRIL 16, 2025
[Sponsored] A webinar on May 8th will explore how a banking platform approach could be a resource for the needs of entrepreneurs across biotech, diagnostics, and other life science companies. The post How Can Fintech Make it Easier for Early Stage Life Science Companies to Grow? appeared first on MedCity News.
Pharma Marketing Network
APRIL 17, 2025
What do you do when the traditional pillars of your marketing strategy start to crumble? For many pharmaceutical companies in 2025, the answer is clear: pivot aggressively toward digital. With geopolitical volatility sparking new tariff threats and mounting legislative scrutiny over pharmaceutical television ads, pharma digital ad spend is experiencing a noticeable surge.
Curzon Consulting
APRIL 17, 2025
The issue Frontline ‘negotiators’ not trained – Teams lacked clarity on effective, strategic negotiations Power balance leaning to suppliers – Although the airport had leverage, suppliers secured favourable contract terms Costs above benchmark – Costs were identifed as 20% to 40% above benchmark for critical success Solution Benchmarking & Research Gained clarity on the as-is situation.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
European Pharmaceutical Review
APRIL 21, 2025
Quality-by-design (QbD) is a systemic risk-management strategy that facilitates the production of safe and consistent drugs. As pharma and biotech companies move towards more complex medicines, it is critical they have contract development and manufacturing organisation (CDMO) partners who can implement QbD principles while maintaining the accelerated timelines required for competitive business.
PharmaVoice
APRIL 21, 2025
SpringWorks Therapeutics and the Children’s Tumor Foundation salvaged a shelved asset for neurofibromatosis and got it over the regulatory finish line.
MedCity News
APRIL 17, 2025
Healthcare organizations need to jump in with both feet when it comes to AI, as mitigating risk is quickly becoming an existential business issue. Machine learning has quickly gone from being a nice-to-have to a must-have. The post Health Plans Can Reduce Costs with a Focus on Rising Risk appeared first on MedCity News.
Pharma Marketing Network
APRIL 22, 2025
Introduction Pharma brands are rethinking their digital engagement strategies in 2025. With regulatory scrutiny evolving and audience expectations shifting, social media marketing plans have become a central focus for companies looking to maintain trust while expanding reach. Social platforms are no longer just optional toolsthey’re vital channels for HCP and patient engagement.
Curzon Consulting
APRIL 17, 2025
The issue Frontline ‘negotiators’ not trained – Teams lacked clarity on effective, strategic negotiations Power balance leaning to suppliers – Although the airport had leverage, suppliers secured favourable contract terms Costs above benchmark – Costs were identifed as 20% to 40% above benchmark for critical success Solution Benchmarking & Research Gained clarity on the as-is situation.
European Pharmaceutical Review
APRIL 16, 2025
The European Commission (EC) has granted a marketing authorization for Leqembi (lecanemab) as the first therapy in the EU targeting an underlying cause of Alzheimers. Eisai Co., Ltd. and Biogen Inc.s amyloid-beta (A) monoclonal antibody is indicated for adults with mild cognitive impairment and mild dementia due to Alzheimers who are apolipoprotein E 4 (ApoE 4*) non-carriers or heterozygotes with confirmed amyloid pathology.
PharmaVoice
APRIL 17, 2025
The non-traditional marketing approach comes amid a potential crackdown on TV drug ads.
MedCity News
APRIL 16, 2025
From the operating room to the front desk, robotics are now being integrated into a variety of applications with the purpose of freeing up time and services for healthcare workers to do what they do best, patient care. The post Healthcares Robotic Renaissance: Meeting Future Demands appeared first on MedCity News.
Advertiser: ZoomInfo
ZoomInfo customers aren’t just selling — they’re winning. Revenue teams using our Go-To-Market Intelligence platform grew pipeline by 32%, increased deal sizes by 40%, and booked 55% more meetings. Download this report to see what 11,000+ customers say about our Go-To-Market Intelligence platform and how it impacts their bottom line. The data speaks for itself!
Pharma Marketing Network
APRIL 21, 2025
Introduction In the ever-evolving world of healthcare promotion, pharma brands are constantly seeking reliable, cost-effective, and targeted strategies to stay connected with healthcare professionals (HCPs) and patients. Enter email marketing campaigns a digital tactic that’s proving to be more than just effective. But are these campaigns truly worth the investment in 2025’s competitive and compliance-heavy landscape?
PM360
APRIL 23, 2025
Partnership strengthens Havas innovation strategy, providing premier access to the fastest-growing AI engagement platform in life sciences. Havas today announced a strategic investment and partnership with Ostro, the trailblazing AI-powered engagement platform built for the life sciences industry. In a world where consumers and healthcare providers (HCPs) are bombarded with information about new healthcare treatment options, Ostro provides a personalized healthcare journey and serves as the AI i
European Pharmaceutical Review
APRIL 18, 2025
Eli Lilly and Company has announced positive topline results for the first oral small molecule glucagon-like peptide-1 (GLP-1) receptor agonist , taken without food and water restrictions, to successfully complete a Phase III trial. “ ACHIEVE-1 is the first of seven Phase III studies examining the safety and efficacy of orforglipron across people with diabetes and obesity.
Expert insights. Personalized for you.
269 
Let's personalize your content